HLB Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 18, 2025	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Market Capitalization	206,562	75,194	58,507	80,206
Market Cap Growth	-37.93%	28.52%	-27.05%	-
Enterprise Value	196,907	77,595	-	-
Last Close Price	14710.00	5430.00	4225.00	6420.00
PE Ratio	437.02	159.09	-	-
PS Ratio	5.72	2.08	2.85	5.16
PB Ratio	11.54	4.20	3.44	4.77
P/TBV Ratio	11.83	4.31	3.50	4.83
P/OCF Ratio	152.64	55.56	-	-
EV/Sales Ratio	5.45	2.15	-	-
EV/EBITDA Ratio	63.92	25.19	-	-
EV/EBIT Ratio	136.65	53.85	-	-
Debt / Equity Ratio	0.74	0.74	0.45	0.89
Debt / EBITDA Ratio	4.28	4.28	-	-
Asset Turnover	0.88	0.88	0.54	-
Inventory Turnover	3.27	3.27	3.13	-
Quick Ratio	1.01	1.01	0.94	1.01
Current Ratio	1.26	1.26	1.31	1.31
Return on Equity (ROE)	2.71%	2.71%	-41.77%	-
Return on Assets (ROA)	2.19%	2.19%	-9.55%	-
Return on Capital (ROIC)	3.23%	3.23%	-12.90%	-
Return on Capital Employed (ROCE)	6.30%	6.30%	-28.80%	-17.40%
Earnings Yield	0.23%	0.63%	-12.07%	-6.79%
FCF Yield	-0.02%	-0.06%	-4.91%	-3.77%
Buyback Yield / Dilution	-2.30%	-2.30%	-13.08%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.